Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.

Author: KhromavaAlena, LedlieShaleesa, LiLin, PanChunshen, RicciChristina, RojasAndrey

Paper Details 
Original Abstract of the Article :
Yellow fever (YF) vaccines are highly effective and have a well-established safety profile despite the risk of rare serious adverse events (SAEs), vaccine-associated neurotropic (YEL-AND) and viscerotropic disease (YEL-AVD). This study aimed to describe US civilian YF vaccine usage, the population c...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.vaccine.2021.12.047

データ提供:米国国立医学図書館(NLM)

Yellow Fever Vaccine Usage in the United States: A Comprehensive Look at Safety and Risk

In the vast and ever-changing desert of public health, we find ourselves navigating the delicate balance between vaccination and the potential for adverse events. This study, using three healthcare databases, provides a comprehensive analysis of yellow fever vaccine usage in the United States, examining the characteristics of vaccinated individuals, pre-existing conditions, and the risk of rare but serious adverse events such as vaccine-associated neurotropic (YEL-AND) and viscerotropic disease (YEL-AVD).

A Deep Dive into Yellow Fever Vaccine Usage and Risk Factors

The authors meticulously analyze the data, providing detailed insights into the population demographics, pre-existing medical conditions, and risk estimates for YEL-AND and YEL-AVD. This comprehensive analysis serves as a valuable resource for healthcare providers, enabling them to make informed decisions regarding yellow fever vaccination strategies.

Navigating the Risks: Balancing Protection and Potential Complications

While yellow fever vaccines offer significant protection against this potentially deadly disease, this study highlights the importance of considering potential risks, particularly in individuals with specific pre-existing conditions. This underscores the need for ongoing research and vigilance in monitoring vaccine safety and effectiveness to ensure optimal patient outcomes.

Dr.Camel's Conclusion

This study, like a guide through a treacherous desert, provides valuable insights into the complexities of yellow fever vaccination. It underscores the importance of a balanced approach, weighing the benefits of vaccination against the potential risks, particularly in individuals with pre-existing medical conditions. This research contributes to a deeper understanding of vaccine safety and the ongoing pursuit of public health initiatives.

Date :
  1. Date Completed 2022-01-26
  2. Date Revised 2022-01-26
Further Info :

Pubmed ID

34996642

DOI: Digital Object Identifier

10.1016/j.vaccine.2021.12.047

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.